Compare WGO & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGO | NVCR |
|---|---|---|
| Founded | 1958 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.5B |
| IPO Year | N/A | 2015 |
| Metric | WGO | NVCR |
|---|---|---|
| Price | $40.16 | $12.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $40.00 | $28.42 |
| AVG Volume (30 Days) | 528.8K | ★ 1.8M |
| Earning Date | 12-19-2025 | 10-30-2025 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ 106.82 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $2,798,200,000.00 | $642,269,000.00 |
| Revenue This Year | $3.24 | $9.75 |
| Revenue Next Year | $5.40 | $5.62 |
| P/E Ratio | $45.49 | ★ N/A |
| Revenue Growth | N/A | ★ 11.17 |
| 52 Week Low | $28.00 | $10.70 |
| 52 Week High | $55.49 | $34.13 |
| Indicator | WGO | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 59.02 | 51.80 |
| Support Level | $39.14 | $12.30 |
| Resistance Level | $41.89 | $13.94 |
| Average True Range (ATR) | 1.78 | 0.66 |
| MACD | 0.22 | 0.07 |
| Stochastic Oscillator | 67.11 | 58.41 |
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.